Welcome to CDC stacks | Current trends disk diffusion antimicrobial susceptibility testing of Neisseria gonorrhoeae - 7338 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Current trends disk diffusion antimicrobial susceptibility testing of Neisseria gonorrhoeae
  • Published Date:
    March 16, 1990
  • Status:
    superseded
    | This document has been replaced by:
  • Source:
    MMWR. Morbidity and mortality weekly report. 1990; 39(10):167-9.
  • Language:
    English
Filetype[HTML]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Corporate Authors:
    Center for Infectious Diseases (U.S.)
  • Pubmed ID:
    2137900
  • Description:
    Antimicrobial resistance in Neisseria gonorrhoeae has developed to each of the agents that have been recommended for gonorrhea therapy (1). As a result, a well-standardized laboratory method to monitor the susceptibilities of gonococcal isolates has been recommended by the National Committee for Clinical Laboratory Standards (NCCLS). The NCCLS recently completed a multicenter study to standardize disk diffusion (and agar dilution) susceptibility tests for N. gonorrhoeae and to establish interpretive criteria and quality-control guidelines (2). The recommended test medium is GC base agar with a defined "XV-like" supplement. Control organisms are N. gonorrhoeae ATCC 49226 (CDC F-18), N. gonorrhoeae WHO V, and Staphylococcus aureus ATCC 25923.

    In PubMed (https://www.ncbi.nlm.nih.gov/pubmed/2137900), the title is recorded as: "Disk diffusion antimicrobial susceptibility testing of Neisseria gonorrhoeae."

  • Document Type:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: